Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 294.89 Million SEK | 19.7% |
| 2022 | 246.35 Million SEK | 31.68% |
| 2021 | 187.08 Million SEK | 31.17% |
| 2020 | 142.62 Million SEK | -8.97% |
| 2019 | 156.67 Million SEK | 15.37% |
| 2018 | 135.79 Million SEK | 11.47% |
| 2017 | 121.81 Million SEK | 26.45% |
| 2016 | 96.33 Million SEK | 15.4% |
| 2015 | 83.47 Million SEK | 2.47% |
| 2014 | 81.46 Million SEK | -8.56% |
| 2013 | 89.09 Million SEK | 1.19% |
| 2012 | 88.04 Million SEK | -2.07% |
| 2011 | 89.9 Million SEK | 7.79% |
| 2010 | 83.41 Million SEK | -17.27% |
| 2009 | 100.81 Million SEK | 4.35% |
| 2008 | 96.61 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 127.85 Million SEK | -10.34% |
| 2024 Q2 | 142.6 Million SEK | 2.09% |
| 2024 Q1 | 139.68 Million SEK | 80.76% |
| 2023 Q1 | 72.42 Million SEK | 17.1% |
| 2023 Q4 | 77.27 Million SEK | 10.23% |
| 2023 FY | 294.89 Million SEK | 19.7% |
| 2023 Q2 | 75.08 Million SEK | 3.68% |
| 2023 Q3 | 70.1 Million SEK | -6.63% |
| 2022 Q1 | 61.63 Million SEK | 3.44% |
| 2022 Q2 | 63.28 Million SEK | 2.69% |
| 2022 Q3 | 59.58 Million SEK | -5.85% |
| 2022 FY | 246.35 Million SEK | 31.68% |
| 2022 Q4 | 61.84 Million SEK | 3.79% |
| 2021 Q1 | 35.77 Million SEK | -20.52% |
| 2021 Q2 | 40.59 Million SEK | 13.47% |
| 2021 FY | 187.08 Million SEK | 31.17% |
| 2021 Q3 | 51.14 Million SEK | 25.99% |
| 2021 Q4 | 59.58 Million SEK | 16.51% |
| 2020 Q3 | 31.5 Million SEK | 7.52% |
| 2020 FY | 142.62 Million SEK | -8.97% |
| 2020 Q2 | 29.3 Million SEK | -20.41% |
| 2020 Q1 | 36.81 Million SEK | -9.82% |
| 2020 Q4 | 45 Million SEK | 42.86% |
| 2019 Q4 | 40.82 Million SEK | 0.39% |
| 2019 FY | 156.67 Million SEK | 15.37% |
| 2019 Q3 | 40.66 Million SEK | 10.5% |
| 2019 Q2 | 36.8 Million SEK | -4.11% |
| 2019 Q1 | 38.38 Million SEK | -8.87% |
| 2018 Q4 | 42.11 Million SEK | 47.8% |
| 2018 Q3 | 28.49 Million SEK | -5.29% |
| 2018 Q2 | 30.08 Million SEK | -14.27% |
| 2018 Q1 | 35.09 Million SEK | -0.6% |
| 2018 FY | 135.79 Million SEK | 11.47% |
| 2017 Q1 | 29.91 Million SEK | 2.21% |
| 2017 FY | 121.81 Million SEK | 26.45% |
| 2017 Q3 | 27.14 Million SEK | -7.8% |
| 2017 Q4 | 35.3 Million SEK | 30.05% |
| 2017 Q2 | 29.44 Million SEK | -1.57% |
| 2016 Q1 | 22.32 Million SEK | -18.06% |
| 2016 Q2 | 22.72 Million SEK | 1.77% |
| 2016 Q4 | 29.26 Million SEK | 32.93% |
| 2016 Q3 | 22.01 Million SEK | -3.1% |
| 2016 FY | 96.33 Million SEK | 15.4% |
| 2015 Q4 | 27.24 Million SEK | 84.46% |
| 2015 Q3 | 14.77 Million SEK | -31.33% |
| 2015 Q2 | 21.51 Million SEK | 7.82% |
| 2015 Q1 | 19.95 Million SEK | -5.87% |
| 2015 FY | 83.47 Million SEK | 2.47% |
| 2014 Q4 | 21.19 Million SEK | 10.96% |
| 2014 Q1 | 22.22 Million SEK | 4.69% |
| 2014 Q2 | 18.95 Million SEK | -14.72% |
| 2014 Q3 | 19.1 Million SEK | 0.8% |
| 2014 FY | 81.46 Million SEK | -8.56% |
| 2013 FY | 89.09 Million SEK | 1.19% |
| 2013 Q4 | 21.22 Million SEK | 0.42% |
| 2013 Q3 | 21.13 Million SEK | -11.3% |
| 2013 Q2 | 23.82 Million SEK | 4.11% |
| 2013 Q1 | 22.88 Million SEK | 13.15% |
| 2012 FY | 88.04 Million SEK | -2.07% |
| 2012 Q2 | 21.5 Million SEK | -8.84% |
| 2012 Q3 | 22.72 Million SEK | 5.66% |
| 2012 Q4 | 20.22 Million SEK | -10.98% |
| 2012 Q1 | 23.59 Million SEK | 0.49% |
| 2011 Q4 | 23.47 Million SEK | 18.17% |
| 2011 Q1 | 24.02 Million SEK | -6.01% |
| 2011 FY | 89.9 Million SEK | 7.79% |
| 2011 Q3 | 19.86 Million SEK | -11.9% |
| 2011 Q2 | 22.54 Million SEK | -6.13% |
| 2010 Q2 | 18.26 Million SEK | -3.3% |
| 2010 Q1 | 18.88 Million SEK | -37.12% |
| 2010 Q3 | 20.7 Million SEK | 13.41% |
| 2010 Q4 | 25.55 Million SEK | 23.41% |
| 2010 FY | 83.41 Million SEK | -17.27% |
| 2009 Q1 | 27.42 Million SEK | 0.0% |
| 2009 Q3 | 17.72 Million SEK | -30.85% |
| 2009 Q2 | 25.63 Million SEK | -6.55% |
| 2009 FY | 100.81 Million SEK | 4.35% |
| 2009 Q4 | 30.03 Million SEK | 69.44% |
| 2008 Q2 | 21.6 Million SEK | -20.22% |
| 2008 Q1 | 27.08 Million SEK | 0.0% |
| 2008 FY | 96.61 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -4625.092% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 78.522% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 78.522% |
| Arcoma AB | 163.01 Million SEK | -80.899% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | -44.562% |
| BICO Group AB (publ) | 2.23 Billion SEK | 86.832% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | 48.385% |
| CellaVision AB (publ) | 677.29 Million SEK | 56.46% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -3464.523% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -30105.75% |
| C-Rad AB (publ) | 424.61 Million SEK | 30.55% |
| Duearity AB (publ) | 1.65 Million SEK | -17729.081% |
| Dignitana AB (publ) | 86.06 Million SEK | -242.648% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -2763.039% |
| Getinge AB (publ) | 31.82 Billion SEK | 99.073% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -4066.163% |
| Integrum AB (publ) | 104.11 Million SEK | -183.228% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -34402.556% |
| Mentice AB (publ) | 273.61 Million SEK | -7.779% |
| OssDsign AB (publ) | 112.15 Million SEK | -162.929% |
| Paxman AB (publ) | 210.11 Million SEK | -40.347% |
| Promimic AB (publ) | 37.07 Million SEK | -695.503% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -120757.787% |
| SciBase Holding AB (publ) | 23.24 Million SEK | -1168.63% |
| ScandiDos AB (publ) | 60.42 Million SEK | -387.999% |
| Sectra AB (publ) | 2.96 Billion SEK | 90.05% |
| Sedana Medical AB (publ) | 153.86 Million SEK | -91.654% |
| Senzime AB (publ) | 35.75 Million SEK | -724.783% |
| SpectraCure AB (publ) | 318 Thousand SEK | -92633.648% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 91.603% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | 50.649% |